News
Videos
Conferences
Events
Resources
Subscribe

|Videos|October 23, 2015

How to Combat CINV

Episodes in this series

EP. 1 Expert Panel Discusses Nausea and Vomiting

EP. 1 Expert Panel Discusses Nausea and Vomiting

EP. 2 Proper Communication With Care Team

EP. 2 Proper Communication With Care Team

EP. 3 Preventing Complications of CINV

EP. 3 Preventing Complications of CINV

EP. 4 How to Combat CINV

EP. 4 How to Combat CINV

EP. 5 Psychological Effects of Nausea and Vomiting

EP. 5 Psychological Effects of Nausea and Vomiting

Newsletter

Stay up to date on cancer updates, research and education

Related Content

After her own breast cancer treatment, Maureen advocated for legislation to make scalp cooling more accessible for patients seeking to preserve their hair.

Breast Cancer Survivor Advocates for Access to Scalp Cooling

ByMaureen Green

November 12th 2025

Image of woman.

What I Learned About Previvorship and Representation in Social Media

ByGeorgia Hurst

November 10th 2025

Image of people.

What Dermatological Side Effects Can Patients With Breast Cancer Expect?

October 28th 2025

Between paying for treatment, managing a reduced income, and understanding insurance, the financial side of cancer can feel overwhelming.

Financial Planning Support for People and Families Impacted by Cancer

ByTriage Cancer®

October 16th 2025

For nearly 30 years, Nora Ambros lived with a constant, painful reminder of her first battle with breast cancer.

A Survivor's 30-Year Wait for Lymphedema Relief Ends with Hackensack's New Supermicrosurgery Robotic Procedure

ByHackensack Meridian Health

October 16th 2025

Trending on CURE

B7-H3 CAR T-Cell Therapy Shows Acceptable Safety in Recurrent Glioblastoma

Giredestrant Shows Benefit for Early Breast Cancer in Phase 3 Trial

Voranigo Plus Temodar Found to Be Safe in Patients With IDH1/2+ Glioma

Early Real-World Uptake of Voranigo in Patients With IDH-Mutant Glioma

Effective Early Treatments Needed in Glioma, Real-World Data Finds

© 2025 MJH Life Sciences^®

All rights reserved.